Absolutely. They mention immunotherapy in the article, and pembro (aka Keytruda) is the best-selling drug in that class. Another big one that was introduced aro

Absolutely. They mention immunotherapy in the article, and pembro (aka Keytruda) is the best-selling drug in that class. Another big one that was introduced around the same time is nivolumab (aka Opdivo). Immunotherapy has really transformed certain parts of oncology (including melanoma, which they mention in the article as well), which is why some of the foundational researchers won the Nobel last year.